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Abstract 
The treatment of chronic diseases with multiple medications as recommended by 
advancements in healthcare guidelines has become a standard of medical practice.  The 
promotion of such guidelines has proven to be beneficial and enhance quality of life in our 
geriatric populations.  The clinical trials that produce such guidelines often exclude older adults 
with comorbid conditions thus making them ungeneralizable to this population.  This lack of 
quality evidence places patients and providers at risk for potentially inappropriate prescribing. 
Explicit tools such as the STOPP/START criteria have been developed to help guide providers in 
making safe choices for elderly patients.  The purpose of this paper is to explain the 
STOPP/START criteria and determine if it is effective in reducing potentially inappropriate 
prescribing in the elderly.  A literature review will also outline the impact that using such a tool 
has on health outcomes of this population as well as comparing the tool to the more widely 
known Beer’s criteria.  Finally, a case report will be analyzed using the STOPP/START criteria 
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Reducing Potentially Inappropriate Prescribing in Geriatrics using the STOPP/START Tool 
Background 
 The past century has witnessed a major shift from the leading causes of death for all age 
groups from infectious disease and acute illnesses to chronic conditions.  In fact, two out of three 
older Americans have multiple chronic conditions (Centers for Disease Control and Prevention 
(CDC), 2013).  Furthermore, patients aged 80 and above suffer from a mean number of 3.3 
chronic medical conditions and on average three drugs are prescribed per disease (Topinkova, 
Baeyens, Michel, & Lang, 2012).   The promotion of the use of clinical guidelines which 
frequently advocates more than one drug to manage common chronic conditions has become the 
standard of medical practice.  These guidelines are widely accepted as beneficial as they are 
supported by a substantial amount of evidence (Cadogan et al., 2015; Patterson et al., 2014).  
Although the clinical trials that are the base of such guidelines are evidence based, they often 
exclude older adults and focus only on a specific disease.  Thus, the use of guidelines in the 
elderly with multiple chronic conditions may lead to potentially inappropriate prescribing by the 
provider (Corsonello et al., 2012).    
Potentially inappropriate prescribing (PIP) is strongly associated with overprescribing but 
it is also associated with misprescribing as well as underprescribing.  Potentially inappropriate 
prescribing has been correlated with increases in morbidity, adverse drug events, hospitalization, 
and mortality (Cahir et al., 2010; Cooper et al., 2015).  The phenomenon of PIP is extremely 
common and several validated explicit criteria tools have been developed to assist providers in 
reducing the frequency of PIP occurrences in the geriatric population.   Explicit tools are 
criterion based and developed from a published review, expert opinion, and consensus 
techniques.  The first widely used tool recognized was the Beers criteria.  Although widely 
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accepted, the Beers criteria do not address many important aspects of PIP such as drug to drug 
interactions, therapeutic duplication, inappropriate duration of therapy, and underprescribing of 
clinically indicated medications.  Furthermore, the Beer’s criteria can be difficult and time 
consuming in daily practice as they are not presented in any particular order or structure 
(Corsonello et al., 2012; P. Gallagher & O'Mahony, 2008).   
The perceived deficiencies of the Beer’s criteria lead to the development of the Screening 
Tool of Older Persons’ Prescriptions (STOPP) and the Screening Tool to Alert Doctors to Right 
Treatment (START).  The STOPP/START criteria have become widely used in Europe and have 
been found to be successfully applied to both research and clinical environments.  A multitude of 
studies have shown its superiority over the Beer’s criteria (O'Mahony et al., 2015).  Thus, this 
text means to provide an overview of this new widely used tool and its implications in practice in 
correlation with a presented case study.   
Case Report 
History of Present Illness  
Mrs. E.S. is an 86-year-old female who presents to the clinic today for a hospital follow 
up visit.  She was hospitalized for three days with a diagnosis of a urinary tract infection.  E.S. 
was discharged on Nitrofurantoin ER 100 mg orally twice per day, she has three days left of this 
course of treatment.  She has a presenting complaint of “feeling more tired than usual” with 
further reports of “feeling dizzy” throughout the day but especially in the early morning after 
positional changes.  E.S. states that these symptoms of fatigue and dizziness began after her 
discharge from the hospital which was four days ago and denies having these symptoms prior to 
her hospitalization.  E.S. reports that her symptoms of dizziness are relieved with “sitting down 
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and resting.”  She also reports that she has been less active since her hospital discharge due to 
her feelings of fatigue.   
History 
 E.S. has an unknown family history and no known allergies.  She lives at an assisted 
living center where nursing staff assist her with medication administration and occasionally 
meals.  Per patient report, she is able to accomplish all activities of daily living independently.  
She denies any surgical history.  Per record review she has a history of dementia, diabetes, 
chronic obstructive pulmonary disease (COPD), anemia, hypertension, depression, and 
neuropathy.  Her current medication list is as follows, Donepezil 5 mg orally daily, Fluticasone 
proprionate and salmeterol 250/50 one puff twice per day, Losartan 50 mg orally daily, 
Metoprolol 50 mg orally twice per day, Gabapentin 300 mg orally three times per day, 
Paroxetine 20 mg orally daily, Quetiapine 200 mg orally twice per day, Insulin Glargine 30 units 
subcutaneous injection every night at bedtime, Multivitamin orally daily, Iron Sulfate 325 mg 
orally daily, and Nitrofurantoin ER 100 mg twice per day with three days left of treatment 
course. History was confirmed with patient at the time of interview. 
Review of Systems 
 E.S. denies fever or weakness. Reports “feeling tired all day long” which has been 
present since hospital discharge four days ago. Reports feeling dizzy in the morning with 
position changes.  Denies hearing loss, pain or discharge. Denies loss of balance.  Denies any 
recent cough or difficulty breathing.  Denies chest pain, palpitations, dyspnea, or orthopnea. 
Denies any edema. Denies ever completing an echocardiogram or having a history or heart 
arrhythmias.  Denies dysphagia, nausea, or vomiting. Denies abdominal or pelvic pain. Denies 
constipation or diarrhea as well as black or tarry stools.  Denies change in diet or fluid intake. 
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Reports drinking one to two 750 ml of water per day.  E.S. reports that she monitors her blood 
glucose twice per week and that her blood glucose levels are “between 110-130.”  Denies urinary 
frequency, urgency, dysuria, or hematuria.  Denies any gait abnormalities, joint pain, or stiffness.  
Denies headaches, lightheadedness, vertigo, syncope, seizures, numbness, gait instability, or 
falls.  No reports of sadness or worry.  Reports good energy and good mood.   
Physical Exam  
 E.S. is well groomed 86-year-old female appearing her stated age.  She appears without 
any apparent distress.  She is alert, oriented to person, place, and time.  Mood is pleasant.  
Speech is fluent, words are clear.  Abstract thinking, attention, comprehension, vocabulary, and 
judgement are appropriate and intact. E.S. is determined to be an accurate reporter of health and 
history.  Vital signs reveal a blood pressure of 88/40, pulse of 50, respirations 24, and a 
temperature or 98.6 degrees Fahrenheit.  
Head, ears, eyes, nose, and throat exam reveals a normocephalic head without masses or 
lesions.  Full distribution of hair on scalp.  Eyebrows are full.  Facial expressions relaxed and 
symmetric without tics or drooping.  Lids are free from redness, scaling, or lesions.  Sclera are 
without hemorrhage or jaundice.  Pupils are equal in size and react equally to light.  External 
auditory canals have minimal cerumen impaction.  No erythema, edema, or drainage noted.  
Tympanic membrane pearly grey in color with cone of light reflection.  Bony landmarks 
identified.  Nose midline without deviation.  Oral mucosa pink, moist, and intact.  Neck supple, 
symmetric, midline without torticollis.  Trachea midline.  Carotid upstrokes are strong without 
bruits.  No cervical lymphadenopathy appreciated.  Thyroid smooth without nodules.   
 Cardiac and respiratory exams were negative.  Findings included easy and regular 
respirations.  Skin without cyanosis.  Breath sounds clear and vesicular to auscultation 
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throughout all lung fields.  No rhonchi, wheezes, or stridor appreciated.  No jugular venous 
distention noted.  Normal S1 and S2 sounds heard without murmurs, rubs, or gallops.  Rhythm 
normal but bradycardia noted.  Carotid, radial, and dorsalis pedis pulses two plus bilaterally 
without bruits.  No edema appreciated, bilateral compression stockings in place.   
 Abdominal and neurological exams are negative.  Findings include an abdomen without 
distention or ascites.  No tenderness to light or deep palpation.  Abdomen soft with normoactive 
bowel sounds in all four quadrants.  Cerebellar functions intact as evidenced by smooth and 
coordinated rapid alternating movements in bilateral upper extremities.  Coordinated heal to shin 
movements.  Gait steady and without difficulty.   
Laboratory Exam  
 To summarize the patient’s pertinent positives, she is noted to having complaints of 
dizziness and fatigue.  She has hypotensive blood pressure at 88/40 with bradycardia at 50 beats 
per minutes (bpm).  Furthermore, she reports feelings of dizziness with position changes which 
would lead to a suspicion of orthostatic hypotension.  Differential diagnosis includes primary vs 
orthostatic hypotension, dehydration, ongoing urinary tract infection, anemia, bradycardia, 
hypothyroidism, and hypoglycemia. Thus laboratory data was ordered as follows, basic 
metabolic panel (BMP), complete blood count (CBC), and a thyroid stimulating hormone (TSH).  
All of the aforementioned serum laboratory work up was within normal limits.  An 
electrocardiogram (EKG) was ordered which revealed sinus bradycardia.   
Assessment and Plan 
 E.S. was diagnosed with hypotension and sinus bradycardia.  Treatment of patient’s 
hypotension and bradycardia was to reduce her Metoprolol dose to 25 mg twice per day.  E.S. 
was thoroughly educated on measures to reduce orthostatic hypotension which included slow 
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position changes and an increase in fluid intake.  E.S.  was also instructed to continue to wear 
compression stockings during day time hours.  Patient has been instructed to monitor blood 
pressure every morning and evening for the next two weeks and return to the clinic for a follow 
up appointment with documented blood pressure readings.  Patient also agrees to return to clinic 
for worsening or change in symptoms. E.S. verbalized understanding.   
Literature Review 
 Prescribing for the older population can become a daunting task.  As stated previously, 
evidence based guidelines have become a staple in the process of treating long term medical 
conditions but the studies of which these guidelines are based often exclude older individuals 
with comorbid conditions, thus they may not be generalizable to this specific population 
(Corsonello et al., 2012).  Providers also need to recognize age related changes that affect drug 
pharmacokinetics and pharmacodynamics which often lead to adverse health outcomes 
(Gallagher & O'Mahony, 2008).  To assist in proper prescribing, several explicit criteria tools 
have been developed.  The Beer’s criteria is the first and most widely used tool of this kind but 
has been found to be deficient in identifying common concerns such as drug to drug interactions, 
therapeutic duplication, inappropriate duration of therapy, and underprescribing of clinically 
indicated medications, thus a new STOPP/START criteria tool was developed. The 
STOPP/START tool has proven to be not only more clinically applicable but superior in many 
areas when compared to the Beer’s criteria (Corsonello et al., 2012; Gallagher & O'Mahony, 
2008; Vélez-Díaz-Pallarés & Cruz-Jentoft, 2014).   
The aforementioned case study detailed a patient experiencing symptoms of dizziness 
and fatigue with findings of hypotension and bradycardia that could be directly correlated with a 
prescribed medication (Metoprolol).  The case emphasizes the need to complete medication 
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reviews in order to reduce not only polypharmacy but the incidents of adverse drug reactions 
(ADR) and PIP.  The literature review that follows will detail the STOPP/START criteria tool 
and its impact on reducing PIP and healthcare outcomes.  There will also be a comparison with 
the widely used Beer’s criteria.  Finally, the STOPP/START tool will be used to evaluate the 
outlined case report.   
Overview of the STOPP/START Criteria Tool 
 The STOPP/START criteria was a European initiative which was led by geriatricians 
from Ireland and the United Kingdom.  The development was promoted by the European Union 
Geriatric Medicine Society with its first publication in 2008 and a subsequent version two being 
released in 2014 (Vélez-Díaz-Pallarés & Cruz-Jentoft, 2014).  The tool is based on evidence and 
was validated by a panel of 18 experts in geriatric pharmacotherapy using a Delphi consensus 
technique (Gallagher & O'Mahony, 2008).  The criteria was developed as the Beer’s criteria had 
limited value in Europe due to the fact that several drugs on the Beer’s criteria were no longer 
available in most European countries.  There was also identification that the Beer’s criteria failed 
to address drug-drug interactions, drug-disease interactions, drug class duplications, and failure 
to include criteria related to underprescribing.  The Beer’s criteria was also thought to be difficult 
to utilize in everyday clinical practice due to its lack user friendly organization (Hill-Taylor et 
al., 2013). 
 Both the STOPP and START portions of the tool are organized according to 
physiological system which enhance their usability.  To enhance their transferability to different 
countries with different formularies, medications are listed per class as opposed to specific drugs 
(Hill-Taylor et al., 2013). The STOPP criteria was developed to identify medications that are 
potentially unnecessary through consideration of drug-drug and drug-disease interactions as well 
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as drug dose and duration (Cahir et al., 2010).   The initial STOPP tool included 65 criteria 
which was recently increased to 87 with the publication of the STOPP/START criteria version 
two developed in 2014.  The STOPP/START tool version two also considers the risk of 
prescriptions in the presence of renal impairment defined by serum creatinine and an estimated 
glomerular filtration rate (Corsonello et al., 2012; Vélez-Díaz-Pallarés & Cruz-Jentoft, 2014).  
The START tool was developed to address omission errors commonly seen within the geriatric 
population.  This included medications that were frequently omitted due to irrational reasons but 
are found to be beneficial to patients in this population (Corsonello et al., 2012).  The START 
tool initially included 22 criteria but has most recently increased to 35 with an inclusion of 
appropriate vaccinations (Vélez-Díaz-Pallarés & Cruz-Jentoft, 2014).   
 Since its first publication, the STOPP/START criteria has been heavily researched.  In 
fact, there have been 74 published articles describing its use since 2008 which have been applied 
to various clinical settings in over 24 countries.  Through a multitude of research articles, the 
STOPP/START clinical tool has continuously proven to be valid and demonstrated a high inter 
rater reliability (Cahir et al., 2010; O'Mahony et al., 2015).  Thus, this tool is thought to be 
applicable in multiple settings and on an international scale.  
Prevalence of PIP Identified Using STOPP/START 
 Prior to analyzing the impact that such a tool has on health outcomes, there needs to be an 
evaluation of the tool and if it accurately detects PIP.  A majority of the evaluations of the 
STOPP/START criteria tool are based on version one as version two has only recently been 
deployed.   
 An observational cross sectional study was completed in Spain in a primary care setting.  
A total of 272 electronic health records were audited and assessed using the STOPP/START 
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criteria.  The population was patients over the age of 65 with at least one medication prescribed 
within the last three months and a mean number of five medications per patients.  The study 
found a prevalence of misprescribing and overprescribing using STOPP version one at a rate of 
37.5% and using version two at 50.7%.  The prevalence of underprescribing using START 
version one at a rate of 45.9% and using version two at 43.0%.  The most prevalent medication 
identified using the STOPP criteria was proton pump inhibitors (PPI) without indication.  The 
most prevalent START medications identified were lack of a prescribed calcium and vitamin D 
supplement in patients with osteoporosis and lack of antiplatelet therapy in diabetic patients with 
coexisting cardiovascular risk factors (Castillo-Paramo et al., 2014).   
 A cross sectional study was completed in a 975 bed teaching hospital in Belgium over a 
12-month period, between the years 2007 and 2008.  This study focused on frail elders who were 
over the age 75 and were admitted to the hospital with an acute illness; a total of 302 subjects 
with 2,028 medications were included in the study.  Data was collected via electronic health 
records and assessed using the STOPP/START criteria.  When using the STOPP criteria, the 
researchers found 210 events of PIP.  They found that 144 of the 302 frail elders were prescribed 
inappropriate medications with a prevalence of 47.7%.  The five most frequently inappropriate 
medications prescribed were benzodiazepines, aspirin, opiates, beta blockers, and tricyclic 
antidepressants.  START criteria identified 362 events of potential prescribing omissions (PPO).  
They found 190 of the 302 frail elders had events of PPO with a prevalence of 62.9%.  The most 
frequently omitted medications were aspirin, statins, metformin, calcium, vitamin D, 
bisphosphonates, warfarin, and bronchodilators (Dalleur et al., 2012). 
 A systematic review was completed which included 12 observational studies and one 
randomized controlled trial (the aforementioned studies were not included in this systematic 
REDUCING PIP USING STOPP/START TOOL  13 
 
review) to assess the sensitivity of the STOPP/START criteria.  The review found that the 
prevalence of patients with at least one incidence of PIP ranged from 21.4% to 79%.  They 
outlined that the most commonly encountered PIP medications were PPIs at full therapeutic 
dosage for longer than eight weeks, use of long acting benzodiazepines for longer than one 
month, and use of neuroleptics as hypnotics for longer than one month.  The prevalence of PPO 
ranged from 22.7% to 74%.  The most encountered PPO medications were calcium with vitamin 
D in patients with osteoporosis, statin therapy with documentation of coronary, cerebral, or 
peripheral vascular disease with a life expectancy longer than five years, and statin therapy in 
patients with diabetes with an elevated cholesterol or additional cardiovascular risks (Hill-Taylor 
et al., 2013).      
Reducing Health Care Outcomes 
 Potentially inappropriate prescribing is associated with an array of medical consequences.  
Polypharmacy has been associated with adverse drug reactions, non-adherence, diminished 
activities of daily living and quality of life, increased health service utilization, cognitive 
impairment, falls, and urinary incontinence (Shah & Hajjar, 2012).  The STOPP/START criteria 
tool has shown promise in reducing some of the consequences of PIP.   
 The cross sectional study detailed previously by Dalleur et al. (2012) found that of the 
302 frail elders admitted to the hospital, 82 admissions were contributed to PIP according to the 
STOPP/START criteria.  Of the 302 admission, 54 were related to inappropriately prescribed 
medications.  Of the 54, 46 admissions involved a fall with a major fracture.  Additionally, of the 
46 patients there were 66 inappropriate medications prescribed which included benzodiazepines 
(35), opiates (13), neuroleptics (12), and antihistamines (2).  PPOs were related to 38 of the 302 
admissions.  These data suggest that 25% of the patients with fall and subsequent fractures had 
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not been receiving calcium with vitamin D or bisphosphonates.  The study determined that acute 
hospital admission was related to both inappropriate prescriptions and omissions at a rate of 18% 
and 13% respectively (Dalleur et al., 2012).    
 A prospective study of 600 patients over the age of 65 who were admitted to a teaching 
hospital over a four-month period found that a total of 329 ADRs were detected in 158 or the 600 
patients.  Of the 329 ADRs, 219 were considered contributory to admission.  They found that 
when STOPP criteria meds were prescribed the risk of ADRs increased significantly with an 
odds ratio of 1.847.  Two of the most significant ADRs contributing to admission were falls 
while receiving benzodiazepines and symptomatic orthostasis while receiving antihypertensives 
(Hamilton, Gallagher, Ryan, Byrne, & O'Mahony, 2011).   
 Perhaps the most convincing evidence comes from a randomized controlled trial (RCT) 
conducted by Gallagher, O’Conner, and O’Mahony (2011) which evaluated 400 hospitalized 
patients over the age 65.  Patients were evaluated using the STOPP/START criteria and 
recommendations were given to the care giving team.  The medications were assessed for 
appropriateness using the Medication Appropriateness Index (MAI) and the Assessment of 
Underutilization Index at the time of discharge and six months’ post discharge. The study found 
that unnecessary polypharmacy, the use of incorrect dosages, and potential drug-drug, and drug 
disease interactions significantly lowered in the intervention group at the time of discharge.  
More specifically, the absolute risk reduction was 35.7% within the intervention group.  
Furthermore, the prevalence of falls and all-cause mortality was lower in the intervention group 
although the differences in both groups was not statistically significant.  The study also 
concluded that the intervention group had a lower frequency of primary care visits within the six-
month period (Gallagher, O'Connor, & O'Mahony, 2011; Hill-Taylor et al., 2013).  
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Comparing STOPP/START to Beer’s 
 Much of the literature in comparing the STOPP/START criteria and the Beer’s criteria is 
outdated due to the fact that both criterion tools have been recently updated.  The 
STOPP/START criteria was updated in 2014 while there was a revision to the Beer’s criteria in 
2012 (Oliveira et al., 2015).  Thus, the information following must be scrutinized due to the lack 
of updated evidence.   
 Initial literature had determined that the STOPP criteria version one was much more 
sensitive than the Beer’s criteria from 2003.  Studies suggested that the STOPP/START criteria 
were able to detect up to 91% of ADR medications while only 48% were detected by the Beer’s 
criteria.  Furthermore, evidence revealed that medications listed on the STOPP/START criteria 
significantly increased ADRs and that the medications listed on the Beer’s Criteria showed no 
association with increased risk to ADRs (Corsonello et al., 2012).  The significance of difference 
between the tools have lessened with the updated version of the Beer’s Criteria.   
 A retrospective cohort study which evaluated medical records of nursing home patients 
over 65 compared the STOPP/START criteria to the newest version of the Beer’s Criteria.  The 
study concluded that due to the patient population and the incidence of sedative medications the 
Beer’s criteria identified more incidents of inappropriate prescribing. However, they determined 
that both sets of criteria identified largely the same patients and that there was no difference in  
the risk of adverse outcomes (Grace et al., 2014).   
A prospective survey was completed on 142 patients 60 years and older within a primary 
care setting in Brazil.  The research indicated that 33.8% of PIP was identified using the STOPP 
criteria while 51.8% were identified using the 2012 Beer’s Criteria.  The study also compared 
REDUCING PIP USING STOPP/START TOOL  16 
 
results using the 2003 Beer’s Criteria which revealed that 34.5% of PIP was identified (Oliveira 
et al., 2015). 
The conclusion that one tool is more sensitive or specific than the latter is difficult to 
determine.  Several studies produce differing results but specific factors must be considered prior 
to forming a conclusion.  Specific factors that may influence the results include which country 
the research was completed and the healthcare setting (Oliveira et al., 2015).  Additionally, in 
order for these tools to remain clinically relevant and valid they must be frequently updated, thus 
comparing frequently updated versions has proven to be challenging.   
Critical Analysis of Literature 
The evidence that was extracted from the literature was ranked using the Oxford Centre 
of Evidence Based Medicine (OCEBM).  The OCEBM was designed to assist clinicians to make 
quick and accurate decisions when confronted with clinical questions.  The OCEBM allows 
clinicians and patients to praise evidence on therapeutic effects and harms as well as prevalence, 
accuracy of diagnostic tests, prognosis, therapeutic effects, rare and common harms, and 
usefulness of screening (Howick et al., 2011).  This particular grading system provides a scale 
from one to five for rating evidence from strongest to weakest using quality of study design and 
susceptibility to bias (OCEBM Levels of Evidence Working Group, 2011).  The author chose to 
use the OCEBM scale to rank the evidence as this grading system is straightforward and easy to 
follow.   
The first question to address is whether the STOPP/START criteria is able to detect PIP 
as it was designed.  The OCEBM tool to evaluate the literature would rank the articles at Level 1 
and Level 3.  Giving a grade B recommendation based on the consistency of the levels of 
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evidence (Centre for Evidence-Based Medicine, 2009).  Concluding that the STOPP/START 
criteria does in fact detect PIP.   
Literature was reviewed to determine if the STOPP/START criteria reducing health care 
outcomes.  The level of evidence for this topic would include Level 1, Level 2, and Level 3 
based on the OCEBM tool, thus giving the evidence a grade B (Centre for Evidence-Based 
Medicine, 2009).  The author would conclude that evidence suggested that this explicit criteria 
tool does have the capability of reducing health care outcomes in the elderly population.   
The literature review also included information comparing the STOPP/START criteria 
with the Beer’s Criteria.  The level of evidence of the articles were consistently Level 3 which 
would give the recommendation a grade B but the conclusion that one method is more clinically 
applicable than the other is much more difficult to determine (Centre for Evidence-Based 
Medicine, 2009).  As previously stated, both tools have been recently updated and very little 
literature exists that compares both updated explicit criteria tools.  Therefore, the argument of 
using the STOPP/START tool over the Beer’s criteria would rest on the conclusion that the 
STOPP/START tool is easier to apply in clinical practice.  The STOPP/START tool is organized 
according to physiological systems and medications are listed per class which enhances both its 
usability and transferability (Hill-Taylor et al., 2013).  Thus, the STOPP/START tools 
organization makes it easy to apply in clinical practice even for a novice practitioner.  
The author must note that the STOPP/START criteria was developed to be more 
applicable in European countries while the Beer’s criteria was developed to be used in the United 
States.  Very few studies researched the impact of the STOPP/START criteria in the United 
States thus a determination that this criterion would be more applicable with the American 
population is inconclusive.  Additionally, it was noted that many of the research studies were 
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conducted by the same authors that developed the original STOPP/START criteria which would 
question the possibility of bias.   
Applying the STOPP/START Criteria to the Case Report 
 The STOPP/START criteria version two was applied to the detailed case report to 
determine if there were any associated PIP occurrences.  The first step in the evaluation would be 
to determine if the patient had an indication for her prescribed medications, if any medications 
were prescribed beyond their recommendation, or if there were any duplicate class prescriptions.  
Evaluation reveals that the patient did have an indication for all prescribed meds, there was no 
medications that were prescribed beyond their recommendation such as PPIs, and there were no 
duplicate class prescriptions.  
As stated previously in the case report, the patient presented with symptoms of 
hypotension and bradycardia which was a direct result of her prescribed beta blocker 
(Metoprolol).  The STOPP criteria details that a beta blocker should be discontinued with a pulse 
less than 50 bpm.  The pulse rate of the patient was 50 bpm and she was symptomatic thus the 
decision to reduce this medication would be supported.  Additionally, the criteria state that beta 
blockers should not be used in patients with diabetes mellitus who suffer from frequent 
hypoglycemic episodes.  Although hypoglycemia was not found in the patient assessment, it 
would be worthy to note follow up blood glucose levels.  The criteria also indicate that 
acetylcholinesterase inhibitors should be withdrawn with a known history of persistent 
bradycardia.  A detailed record of the patient’s previous pulse rates was not provided but should 
be evaluated in the future to determine if this medication should be continued based on her vital 
signs.   
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Further review of the criteria and medication list resulted in drugs that should be 
discontinued according to the STOPP criteria if the listed reactions arise.  The patient is on an 
angiotensin receptor blocker (Losartan) which should be discontinued in patients with 
hyperkalemia.  E.S. is also taking a selective serotonin re-uptake inhibitor (Paroxetine) which 
should be discontinued in the presence of hyponatremia.  The patient is also taking a neuroleptic 
antipsychotic (Quetiapine) which should not be prescribed in the presence of Parkinson’s or 
Lewy Body disease.  As stated, the patient is not currently presenting with the symptoms or lab 
values which would indicate a discontinuation of these medications but further monitoring would 
be warranted.   
Finally, the medication and diagnosis list was compared to the START criteria.  The 
evaluation revealed that the patient was already on all of the recommended medications based on 
her diagnosis list.  The meds include an inhaled beta 2 agonist and inhaled corticosteroid for 
COPD, an acetylcholinesterase inhibitor for mild to moderate dementia, and an angiotensin 
receptor blocker with diabetes.  Other considerations for follow up would be the 
recommendation for her influenza and pneumococcal vaccinations. The patient does not have a 
history of osteoporosis listed but it would be recommended that a calcium/vitamin D supplement 
or bisphosphonate be initiated in the presence of a diagnosis. Thus, an evaluation of the need for 
a Dexa scan should be considered. Additionally, a vitamin D supplement is recommended if the 
patient becomes home bound.   
 After review of the patient’s case using the STOPP/START criteria the author would 
conclude that the tool is helpful in guiding the patient’s treatment plan.  The tool was very 
straightforward and easy to follow which makes it clinically applicable.  The 2012 Beer’s criteria 
was also evaluated and was found to be beneficial.  The Beer’s criteria was more difficult to 
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evaluate based on the patient’s medications and history but with persistent use it would prove to 
be as beneficial as the STOPP/START criteria.  Furthermore, the author would conclude that 
using the STOPP/START criteria would not have prevented the patient’s hospitalization but may 
prevent further adverse health outcomes due to ADRs.  
Conclusion 
Over the next 25 years, the portion of the population over the age of 65 in the United 
States is expected to double and exceed 89 million by the year 2050 (Centers for Disease Control 
and Prevention (CDC), 2013).  If life expectancy continues to increase as projected, there will be 
a correlated increase in the prevalence of chronic conditions.  With a lack of evidence to support 
the use of guidelines in this population, providers need additional tools to assist in their 
prescription practices.  The START/STOPP criteria has proven to be a valid tool that is reliable 
and results in outcomes that increase the identification of PIP as well as decreasing adverse 
health outcomes related to prescription medications.  Thus, using the STOPP/START criteria in 
addition to clinical assessment and judgement shows promise in enhancing the geriatric patient’s 
quality of life.   
Learning Points 
 Medication review to detect PIP is imperative in older adults to reduce adverse health 
outcomes related to medication overuse, misuse, and underuse 
 The STOPP/START criteria has proven to be a valid and reliable tool in detecting PIP 
 The STOPP/START criteria can reduce adverse health care outcomes by addressing PIP  
 The use of explicit tools such as the STOPP/START criteria and the Beer’s criteria are 
meant to be a supplementation to provider’s prescriptive practices 
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